Local Institution - 0023

Madrid 28050

1 studies enrolling now · 6 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumors, Advanced or Metastatic Solid Tumors, Cancer, Melanoma, Solid Tumours

Studies at this site

• A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors — Recruiting now
• A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers — Completed
• An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers — Completed
• A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors — Completed
• A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors — Completed
• A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors — Completed